Safety & Efficacy of Taribavirin when given with IFN-alfa 2b versus the Standard of Care
Comparison of Weight-based Doses of Taribavirin Combined With Peginterferon Alfa 2b Versus Ribavirin Combined With Peginterferon Alfa-2b in Therapy-naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection
The primary purpose of this study is evaluate the safety and efficacy of Taribavirin when given with IFN-alfa 2b vs. ribavirin given with IFN-alfa 2b (the standard of care).
Naïve No cirrhotics
- GT 1 -ANC >1200/mm3
- -PLT >90,000
- -Hb >13g/dL males >12g/dL females
- -AFP <20 ng/mL If >20, neg. imaging within 6 mo.
Last UpdateMarch 25, 2011